ArticleCancer research and treatment2023

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.

So Heun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.